Author

Martin E Hale

Observed names: Hale, Martin E., M E Hale, M. Hale, Martin E. Hale, Martin E. Hale, MD, Martin Hale

Observed institutions: Pfizer (United States), Nova Southeastern University, Endo Pharmaceuticals (United States), Gold Coast City Council, Carolinas Pain Institute, Purdue Pharma (United States)

ORCID: 0000-0001-7222-970X

Observed ORCID: 0000-0001-7222-970X

OpenAlex ID: A5021286381

Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial.

1999 · J R Caldwell, M E Hale, et al. · PubMed · 213

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study

2006 · Martin E. Hale, Harry Ahdieh, et al. · Journal of Pain · 168

Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study

2004 · Martin E. Hale, Chris Dvergsten, et al. · Journal of Pain · 151

Efficacy and Safety of Controlled-Release Versus Immediate-Release Oxycodone: Randomized, Double-Blind Evaluation in Patients with Chronic Back Pain

1999 · Martin E. Hale, Roy Fleischmann, et al. · Clinical Journal of Pain · 134

Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study

2009 · Martin Hale, David Upmalis, et al. · Current Medical Research and Opinion · 131

Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials

2017 · Martin Hale, James Wild, et al. · The Lancet. Gastroenterology & hepatology · 130

Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study

2007 · David M. Simpson, John Messina, et al. · Clinical Therapeutics · 98

Lidocaine Patch Treatment in Patients with Low Back Pain: Results of an Open-Label, Nonrandomized Pilot Study

2005 · Joseph Gimbel, Richard Linn, et al. · American Journal of Therapeutics · 88

Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain

2010 · M. Hale, A. Khan, et al. · Current Medical Research and Opinion · 82

Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis

2007 · Martin Hale, Iulia Cristina Tudor, et al. · Clinical Therapeutics · 82

Efficacy and Safety of Buprenorphine Transdermal System (BTDS) for Chronic Moderate to Severe Low Back Pain: A Randomized, Double-Blind Study

2011 · Deborah Steiner, Catherine Munera, et al. · Journal of Pain · 80

Benefit-Risk Analysis of Buprenorphine for Pain Management

2021 · Martin Hale, Mark Garofoli, et al. · Journal of Pain Research · 54

PDF

Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules in Patients with Chronic Osteoarthritis Pain

2010 · Nathaniel Katz, Martin Hale, et al. · Postgraduate Medicine · 53

Abuse-Deterrent Formulations of Prescription Opioid Analgesics in the Management of Chronic Noncancer Pain

2016 · Martin E Hale, Derek Moe, et al. · Pain Management · 45

PDF

Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial

2005 · Martin K. Childers, David Borenstein, et al. · Current Medical Research and Opinion · 44

IV Acetaminophen

2014 · Neil K. Singla, Martin E. Hale, et al. · American Journal of Therapeutics · 39

SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain

2019 · John Markman, Jeffrey Gudin, et al. · Pain · 32

Long-term safety and analgesic efficacy of buprenorphine buccal film in patients with moderate-to-severe chronic pain requiring around-the-clock opioids

2017 · Martin Hale, Veronica Urdaneta, et al. · Journal of Pain Research · 29

PDF

A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment

2015 · Richard L. Rauck, Martin E. Hale, et al. · Pain · 29

Efficacy of 12 Hourly Controlled‐Release Condeine Compared with as Required Dosing of Acetaminophen Plus Codeine in Patients with Chronic Low Back Pain

1997 · Martin E Hale, Kevin L Speight, et al. · Pain Research and Management · 20

PDF

Buprenorphine Buccal Film for Chronic Pain Management

2020 · Martin Hale, Joseph Gimbel, et al. · Pain Management · 19

PDF

Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age

2020 · James Wild, Lynn Webster, et al. · Drugs & Aging · 19

PDF

Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain

2015 · Martin E. Hale, MD, Thomas R. Zimmerman, MD, et al. · Journal of Opioid Management · 19

Onset of action of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: results from 2 randomized, placebo-controlled, phase 3 trials

2019 · James Wild, Tadaaki Yamada, et al. · Pain · 17

Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation

2021 · Jan Tack, Michael Camilleri, et al. · Clinical Gastroenterology and Hepatology · 16

PDF

Works count: 72

Citation count: 1,934

H-index: 20

I10-index: 31